IMA Advisory Services’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
AIM
VPM
VCM
MCMU
IMA Advisory Services's RXRX Position: Q1 2026 in Review
IMA Advisory Services increased its Recursion Pharmaceuticals (RXRX) stake by 38% in Q1 2026, buying an estimated $452 and bringing the position to 422 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #738.
IMA Advisory Services first reported a position in RXRX in Q4 2025 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.
- IMA Advisory Services held 422 shares of Recursion Pharmaceuticals worth $1.29K as of Q1 2026.
- IMA Advisory Services bought 117 Recursion Pharmaceuticals shares in Q1 2026, an estimated $452.
- Recursion Pharmaceuticals made up ﹤0.01% of IMA Advisory Services's portfolio in Q1 2026, its #738 holding.
- IMA Advisory Services first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
- 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.
Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.